Company profile

Dendropharm

VZP0959 | Berlin

Support us in solving the opiod crisis - invest into our novel dendritic analgesic which has the power of opiates but without side effects - no sedation, no constipation, no addiction. To balance risk - we also develop generica plus - enhanced generica for the veterinary market. Join us to become a game changer in pharma. Help millions of patients and earn millions of Euro.

Business Model

Technology Development

Industry

  • Chemicals/Pharmaceuticals

Customer Focus

B2B

Registered Office

Lankwitzer Str. Lankwitzer Str.
12107 Berlin
Germany

Contact